What is the recommended protocol for Group B Streptococcus screening at 35–37 weeks gestation and intrapartum antibiotic prophylaxis, including regimens for penicillin‑allergic patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Group B Streptococcus Screening and Intrapartum Antibiotic Prophylaxis

Universal Screening Protocol

All pregnant women should undergo vaginal-rectal GBS screening between 36 0/7 and 37 6/7 weeks of gestation using a single swab collected first from the lower vaginal introitus, then inserted through the anal sphincter into the rectum. 1

  • The CDC previously recommended screening at 35-37 weeks, but ACOG now specifies 36 0/7-37 6/7 weeks as the optimal window 2, 1
  • Use a single swab (or two separate swabs) without a speculum—cervical, perianal, perirectal, or perineal specimens are unacceptable 2, 3
  • Place swabs in non-nutritive transport medium (Stuart's or Amies with or without charcoal) and refrigerate if processing is delayed 2, 3
  • Laboratories should incubate specimens 1-4 hours at 35-37°C in enrichment broth, then subculture onto blood agar to maximize GBS recovery 2, 3
  • A negative screen remains valid for only 5 weeks; beyond this, rescreening is required 3, 4

Indications for Intrapartum Antibiotic Prophylaxis

Administer IV antibiotics during labor to women with:

  • Positive GBS vaginal-rectal culture at 36 0/7-37 6/7 weeks 1, 4
  • GBS bacteriuria at any concentration during any trimester of current pregnancy (regardless of whether the UTI was treated) 2, 5, 6
  • Previous infant with invasive GBS disease 2, 3, 6
  • Unknown GBS status at labor onset with delivery <37 weeks' gestation 2, 3
  • Unknown GBS status with membrane rupture ≥18 hours 2, 3
  • Unknown GBS status with intrapartum temperature ≥38.0°C (100.4°F) 2, 3

Do not routinely give prophylaxis for planned cesarean delivery before labor onset with intact membranes, even if GBS-positive. 4, 1

Antibiotic Regimens

For Women Without Penicillin Allergy

Penicillin G remains the agent of choice: 5 million units IV initially, then 2.5-3.0 million units IV every 4 hours until delivery 2, 5, 4

  • Ampicillin is an acceptable alternative: 2 g IV initially, then 1 g IV every 4 hours until delivery 2, 5, 4
  • Penicillin G is preferred due to its narrow spectrum and universal GBS susceptibility 2, 5
  • Prophylaxis should be administered ≥4 hours before delivery for maximum effectiveness (78% reduction in early-onset disease), though even 2 hours provides benefit 5, 1

For Penicillin-Allergic Women

Risk stratification is essential: Women with history of anaphylaxis, angioedema, respiratory distress, or urticaria after penicillin or cephalosporin are considered high-risk for anaphylaxis 2

For low-risk allergy (no history of anaphylaxis, angioedema, respiratory distress, or urticaria):

  • Cefazolin: 2 g IV initially, then 1 g IV every 8 hours until delivery 2, 5, 4

For high-risk allergy:

  • Order clindamycin and erythromycin susceptibility testing on the antenatal GBS isolate 2, 5, 6
  • If susceptible to both clindamycin and erythromycin: Clindamycin 900 mg IV every 8 hours until delivery 2, 5, 4
  • If resistant to either antibiotic or susceptibility unknown: Vancomycin 1 g IV every 12 hours until delivery 2, 5, 4
  • Perform D-zone testing on isolates that are erythromycin-resistant but clindamycin-susceptible to detect inducible clindamycin resistance 2, 5

Special Clinical Scenarios

Preterm Labor or PPROM (<37 weeks)

  • Screen immediately for GBS unless a negative culture was obtained within the prior 5 weeks 3, 6
  • Initiate IV GBS prophylaxis at hospital admission while awaiting culture results 5, 3
  • Continue prophylaxis for minimum 48 hours or discontinue if not in true labor and culture returns negative 5, 6
  • For PPROM ≥24 weeks: Ampicillin 2 g IV once, then 1 g IV every 6 hours for at least 48 hours provides both latency prolongation and GBS prophylaxis 5

GBS Bacteriuria in Pregnancy

  • Treat the acute UTI immediately according to standard pregnancy protocols 5, 6
  • Critical: Treating the UTI does NOT eliminate GBS colonization—intrapartum IV prophylaxis remains mandatory regardless of when the UTI was treated 5
  • Do not rescreen these women at 36-37 weeks; they automatically qualify for intrapartum prophylaxis 5
  • Laboratories should report GBS in urine at concentrations ≥10,000 CFU/mL 2, 5

Critical Pitfalls to Avoid

Never treat asymptomatic GBS vaginal colonization with oral or IV antibiotics before labor—this is completely ineffective at eliminating carriage, does not prevent neonatal disease, and promotes antibiotic resistance. 2, 5, 4

  • Approximately 10% of penicillin-allergic patients also react to cephalosporins, making allergy history assessment crucial 5
  • Clindamycin resistance ranges 3-15% and erythromycin resistance 7-21% among GBS isolates, necessitating susceptibility testing for high-risk allergic patients 5
  • Obstetric interventions should not be delayed solely to achieve 4 hours of antibiotic administration, as even 2 hours provides benefit 1
  • Studies show inadequate screening (51.5% in one cohort) and incomplete IAP administration (50% in another) contribute to preventable neonatal infections 7, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guidelines for Group B Streptococcus Screening and Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of GBS-Positive Women in Labor

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Group B Streptococcal UTI in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The prevention of early-onset neonatal group B streptococcal disease.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2013

Research

Screening and management of maternal colonization with Streptococcus agalactiae: an Italian cohort study.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016

Related Questions

At what gestational age should Group B Streptococcus (GBS) swabs be collected in pregnancy?
What are the treatment guidelines for a pregnant woman with a sore throat suspected to be Group B Streptococcus (GBS)?
At what gestational age should a group B strep (Group B Streptococcus) swab be performed?
What are the management and treatment options for a newborn born via C-section (cesarean section) to a GBS (Group B streptococcus)-positive mother who did not receive intrapartum antibiotic prophylaxis (IAP)?
What test is indicated for a 33-year-old gravida 2 para 1 woman at 26 weeks gestation with a history of Group B Streptococcus (GBS) colonization, now presenting with minimal pedal edema and normal urinalysis results?
What is the recommended tinidazole dose for a 12‑year‑old adolescent weighing at least 35 kg for infections such as giardiasis, trichomoniasis, amoebiasis, bacterial vaginosis, or anaerobic abdominal infections?
What are the possible causes of leg weakness?
What are the most effective biofilm‑disrupting agents for intestinal methanogen overgrowth (IMO)?
In a middle‑aged man with a sharp metallic object penetrating the globe, what is the immediate next step in management?
When can blood pressure targets be liberalized after an acute uncomplicated aortic dissection?
What is the recommended treatment for a confirmed Helicobacter pylori infection, including the preferred first‑line regimen in regions with high clarithromycin resistance, alternative regimens for low resistance or penicillin allergy, and the appropriate post‑therapy eradication testing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.